Brazil's Health Agencies Warn Against Intravenous Vitamin Therapy for Wellness
Brazil's National Health Surveillance Agency (Anvisa) and the Federal Council of Medicine (CFM) have issued warnings regarding "sorotherapy," an intravenous administration of substances like vitamins, iron, and minerals marketed for rejuvenation and well-being. The CFM states that this procedure is not recognized for wellness purposes, and vitamin use must strictly follow individualized medical indications. Emmanuel Fortes, Vice President of the CFM, emphasized that promising aesthetic results or guaranteed benefits from such treatments violates medical practice principles, as medicine cannot guarantee specific outcomes. Anvisa has noted an increase in reported complications from vitamin supplementation, both oral and intravenous. In 2024, there were 164 cases; in 2025, 169 cases; and 85 cases by July of the current year. These incidents primarily involve Vitamin D (cholecalciferol), Vitamin B1 (thiamine), and Vitamin C (ascorbic acid). Anvisa cautions that excessive vitamin intake without medical prescription can lead to hypervitaminosis, with symptoms ranging from nausea and itching to severe kidney and liver damage. The agency also highlighted that no products are registered for sorotherapy for aesthetic or wellness purposes and warned against treatments advertised as miracle cures, urging the public to be skeptical and seek reliable information.
The promotion of intravenous vitamin therapy for general wellness and aesthetic enhancement, despite lacking scientific endorsement for these specific applications, highlights a growing market trend capitalizing on consumer desires for quick health solutions. Regulatory bodies like Anvisa and CFM are intervening to address potential health risks, including hypervitaminosis and complications from unregulated procedures. This situation reflects a broader challenge in distinguishing evidence-based medical treatments from commercially driven wellness trends, particularly in the digital age where unsubstantiated claims can rapidly disseminate. The core issue lies in managing public expectations and ensuring that therapeutic interventions are grounded in rigorous scientific validation and individualized medical necessity, rather than broad, unproven promises. Future regulatory frameworks may need to adapt to better scrutinize and govern such wellness-focused interventions to safeguard public health.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.